Switzerland · Delayed Price · Currency is CHF Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CHF 178.39 billion. The enterprise value is 199.05 billion.
| Market Cap | 178.39B |
| Enterprise Value | 199.05B |
Important Dates
The last earnings date was Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
Novartis AG has 1.94 billion shares outstanding. The number of shares has decreased by -3.37% in one year.
| Current Share Class | 1.94B |
| Shares Outstanding | 1.94B |
| Shares Change (YoY) | -3.37% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 39.08% |
| Float | 1.84B |
Valuation Ratios
The trailing PE ratio is 16.92 and the forward PE ratio is 13.43. Novartis AG's PEG ratio is 1.45.
| PE Ratio | 16.92 |
| Forward PE | 13.43 |
| PS Ratio | 4.06 |
| PB Ratio | 5.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.61 |
| P/OCF Ratio | 10.79 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.47, with an EV/FCF ratio of 12.95.
| EV / Earnings | 18.33 |
| EV / Sales | 4.54 |
| EV / EBITDA | 10.47 |
| EV / EBIT | 13.06 |
| EV / FCF | 12.95 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.
| Current Ratio | 0.82 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 1.69 |
| Interest Coverage | 17.47 |
Financial Efficiency
Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 32.49% |
| Return on Assets (ROA) | 11.88% |
| Return on Invested Capital (ROIC) | 16.47% |
| Return on Capital Employed (ROCE) | 26.39% |
| Revenue Per Employee | 578,368 |
| Profits Per Employee | 143,099 |
| Employee Count | 75,883 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Novartis AG has paid 1.57 billion in taxes.
| Income Tax | 1.57B |
| Effective Tax Rate | 12.62% |
Stock Price Statistics
The stock price has decreased by -2.18% in the last 52 weeks. The beta is 0.53, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -2.18% |
| 50-Day Moving Average | 94.98 |
| 200-Day Moving Average | 94.31 |
| Relative Strength Index (RSI) | 36.21 |
| Average Volume (20 Days) | 2,743,071 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CHF 43.89 billion and earned 10.86 billion in profits. Earnings per share was 5.45.
| Revenue | 43.89B |
| Gross Profit | 33.48B |
| Operating Income | 15.25B |
| Pretax Income | 12.41B |
| Net Income | 10.86B |
| EBITDA | 18.80B |
| EBIT | 15.25B |
| Earnings Per Share (EPS) | 5.45 |
Balance Sheet
The company has 5.35 billion in cash and 25.96 billion in debt, giving a net cash position of -20.60 billion or -10.64 per share.
| Cash & Cash Equivalents | 5.35B |
| Total Debt | 25.96B |
| Net Cash | -20.60B |
| Net Cash Per Share | -10.64 |
| Equity (Book Value) | 33.44B |
| Book Value Per Share | 17.25 |
| Working Capital | -4.59B |
Cash Flow
In the last 12 months, operating cash flow was 16.53 billion and capital expenditures -1.16 billion, giving a free cash flow of 15.37 billion.
| Operating Cash Flow | 16.53B |
| Capital Expenditures | -1.16B |
| Free Cash Flow | 15.37B |
| FCF Per Share | 7.94 |
Margins
Gross margin is 76.28%, with operating and profit margins of 34.76% and 24.74%.
| Gross Margin | 76.28% |
| Operating Margin | 34.76% |
| Pretax Margin | 28.28% |
| Profit Margin | 24.74% |
| EBITDA Margin | 42.84% |
| EBIT Margin | 34.76% |
| FCF Margin | 35.02% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.82%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.82% |
| Dividend Growth (YoY) | 6.06% |
| Years of Dividend Growth | 28 |
| Payout Ratio | 57.26% |
| Buyback Yield | 3.37% |
| Shareholder Yield | 7.19% |
| Earnings Yield | 6.09% |
| FCF Yield | 8.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.
| Last Split Date | May 7, 2001 |
| Split Type | Forward |
| Split Ratio | 40 |
Scores
Novartis AG has an Altman Z-Score of 3.73 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | 6 |